PubMed Health⌕ Search

PubMed · 16418673

Angiosarcoma metastatic to the orbit.

Abstract

A 61-year-old woman developed metastatic angiosarcoma in her left orbit. Diagnosis was confirmed with an incisional orbital biopsy and special markers. Treatment and palliation involved the use of multiple cycles of paclitaxcel, doxorubicin, and ifosfamide along with adjuvant radiotherapy. The measured outcome was tumor mass reduction and mortality. Angiosarcoma was confirmed with histologic analysis. The patient responded to the chemotherapy with reduction of the tumor mass. However, the disease progressed off the medications. She finally died. However, she survived longer than the patient in the only other similar case report. Chemotherapy may be a useful palliative adjunct in the control of metastatic orbital angiosarcoma. Chemotherapy is unlikely to be curative but useful and an adjunct to surgery and radiation therapy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Michael Brush, Jing Zhang, Scott Schuetze, Bryan Sires. Angiosarcoma metastatic to the orbit.. https://doi.org/10.1097/01.iop.0000195230.19378.bf

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗